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Abstract
WWOX is a >1Mb gene spanning FRA16D Common Chromosomal Fragile Site, a region of
DNA instability in cancer. Consequently, alteredWWOX levels have been observed in a
wide variety of cancers. In vitro studies have identified a large number and variety of poten-
tial roles for WWOX. Although its normal role in vivo and functional contribution to cancer
have not been fully defined, WWOX does have an integral role in metabolism and can sup-
press tumor growth. Using Drosophila melanogaster as an in vivomodel system, we find
that WWOX is a modulator of TNFα/Egr-mediated cell death. We found that altered levels of
WWOX can modify phenotypes generated by low level ectopic expression of TNFα/Egr and
this corresponds to altered levels of Caspase 3 activity. These results demonstrate an in
vivo role for WWOX in promoting cell death. This form of cell death is accompanied by an
increase in levels of reactive oxygen species, the regulation of which we have previously
shown can also be modified by altered WWOX activity. We now hypothesise that, through
regulation of reactive oxygen species, WWOX constitutes a link between alterations in cel-
lular metabolism observed in cancer cells and their ability to evade normal cell death path-
ways. We have further shown that WWOX activity is required for the efficient removal of
tumorigenic cells from a developing epithelial tissue. Together these results provide a
molecular basis for the tumor suppressor functions of WWOX and the better prognosis
observed in cancer patients with higher levels of WWOX activity. Understanding the con-
served cellular pathways to which WWOX contributes provides novel possibilities for the
development of therapeutic approaches to restore WWOX function in cancer.
Introduction
Evasion of cell death and altered metabolism are recognized as hallmarks of cancer cells, whilst
DNA instability is one of the enabling characteristics [1]. The FRA16D Common Chromo-
somal Fragile Site (CCFS) spanning gene,WW domain containing oxidoreductase (WWOX),
participates in each of these phenomena and therefore its perturbation in cancer cells presents
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multiple possible avenues for contributing to cancer cell biology. CCFS are specific regions of
chromosomes that can be induced to break in vitro by inhibitors of DNA polymerase and are
affected by certain dietary or environmental factors [2–3]. More than 70 common fragile sites
have been identified in the human genome and it has been observed that there is a hierarchy of
sensitivity in vitro that is matched by the frequency with which these sites show in vivo DNA
instability in various cancers [4]. Of these fragile sites, FRA3B and FRA16D have been shown
to be the most frequent regions of recurrent homozygous deletion in cancer cell lines [5]. CCFS
are typically located within extremely large genes (i.e. FRA3B in 1.5 Mb FHIT gene, FRA16D in
1.1 MbWWOX gene), a relationship that is conserved in mice and suggestive of biological sig-
nificance [4, 6]. DNA instability at these sites, resulting in deletion(s) and / or localised rear-
rangements, is associated with alterations to CCFS-associated gene expression [7–8].
Altered expression ofWWOX has been reported for many different cancer cell types
(reviewed in [9–11]). In addition, low expression alleles ofWWOX were found at a higher fre-
quency in patients with lung cancer [12] or glioma [13], consistent with decreasedWWOX as a
predisposing factor for tumorigenesis.WWOX hypomorphic mice showed an increased inci-
dence of B-cell lymphoma [14] and mice heterozygous forWWOX exhibit higher rates of
tumor growth [15], however the tumor cells still express WWOX protein indicating a lack of
the typical ‘second-hit’ somatic mutation that is characteristic of classical tumor suppressors.
Thus it appears that a reduced level of WWOX activity is sufficient for contribution to cancer
progression. Conversely, ectopically expressed WWOX has been shown to function as a sup-
pressor of tumor growth since restoration of WWOX activity in cancer cells inhibits their
growth in vivo [16–20]. Correlation of higher WWOX expression with better prognosis has
also been reported for various types of cancer including colon, breast and bladder [21–23].
Therefore the pathways that WWOX normally participates in, and the nature of this participa-
tion, are of considerable interest for their likely causal and therapeutically targetable contribu-
tion to cancer cell biology.
WWOX encodes an enzyme with short-chain dehydrogenase/reductase (SDR) activity in
addition to twoWW domains that facilitate protein-protein interactions. WWOX has been
implicated in a diverse range of cellular pathways and processes in mammalian studies by vir-
tue of its physical and / or functional interactions with other proteins or pathways (reviewed in
[24–26]). Whilst various functions for WWOX have been revealed in vitro, it is difficult to
assess their relative significance and contribution to cancer in vivo. A role for WWOX in
metabolism has been established through the analysis of knockout models in mouse, rat and D.
melanogaster [14–15,27–30]. The protein encoded byWWOX has been found not only to con-
tribute to cellular metabolism but also is, in turn, regulated by the relative level of glycolysis
versus oxidative phosphorylation [31]. WWOX has also been widely reported to play a role in
apoptotic pathways, principally through interactions with the tumor suppressor p53 (reviewed
in [24–32]). A pro-apoptotic role for WWOX in vitro has previously been reported for many
different cancer cell types; multiple myeloma [33], colon [34], gall bladder [35], cervical [36],
leukaemic [37], glioblastoma [38–39], hepatoma [40], lung [17], pancreatic [18] and squamous
epithelia [41]. However the molecular mechanism(s) by which WWOX contributes to cell
death pathways in vivo has not been determined. The genetically tractable system of D.melano-
gaster is an effective system in which to dissect various aspects of the contribution of WWOX
to cellular pathways. Herein we determine the role of WWOX in modulating TNFα-mediated
cell death through regulation of Caspase 3 activity. In addition we are able to demonstrate a
requirement for WWOX in the elimination of tumorigenic cells, thus supporting a requirement
for WWOX function early in the tumorigenic process for the removal of abnormal cells.
WWOX and the Elimination of Tumorigenic Cells
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Results
Altered WWOXmodulates ectopic Egr/TNFα eye phenotypes
Ectopically expressed WWOX has been shown to enhance the in vitro cytotoxicity of TNFα in
various tissue culture cell lines [42], yet the contribution of WWOX to TNFα-mediated cell
death in vivo has not been determined. D.melanogaster has a single ortholog to TNFα encoded
by the EDA-like cell death trigger or Eiger (Egr) gene [43–44]. Genetic modification analyses
have previously revealed a number of metabolic genes that are rate-limiting in their contribu-
tion to Egr/TNFα-induced cell death phenotypes in the D.melanogaster eye [45]. TheWWOX
gene has been identified as participating in aerobic metabolism in D.melanogaster [30] and
thus also represents a candidate for contributing to Egr/TNFα-mediated cell death. Ectopic
over-expression of a low level expression construct for Egr/TNFα in the eye during its develop-
ment results in a phenotype characterised by disruption to the precise patterning of repeated
ommatidial units on the external surface of the eye as well as a decrease in overall size (Fig 1A
and [46]) when compared to a control eye (Fig 2D). This Egr/TNFα phenotype was completely
suppressed by RNAi-mediated knockdown of wengen, a gene that encodes the D.melanogaster
TNF receptor (TNFR) thus confirming the specificity of the ectopic Egr/TNFα-mediated phe-
notype (Fig 1B and [47–48]). Introduction of aWWOX knockdown construct (WWOX-IR#1)
resulted in suppression of the Egr/TNFα-mediated rough eye phenotype evident as restoration
of ommatidial patterning across the surface of the eye as well as an increase in eye size (Fig 1C
and 1D). A similar suppression of eye size was observed with an independentWWOX knock-
down construct as well as in flies heterozygous forWWOX loss-of-function mutant alleles (S1
Fig). This indicates that WWOX can contribute to low level Egr/TNFα-mediated cell death.
Ectopic expression ofWWOX alone does not result in any obvious cell death-induced pheno-
type in the biological context of theD.melanogaster eye (S1 Fig). Ectopic over-expression of
WWOX cDNA showed enhancement of the Egr/TNFαmediated mild rough eye phenotype evi-
dent as further disruption to ommatidial patterning and a significant decrease in eye size (Fig 1E
and 1F). A decrease in adult eye size was also observed with ectopic over-expression of an open
reading frame (ORF) encodingWWOX although these results were more variable despite compa-
rable levels of expression ofWWOX (Fig 1F and S1 Fig). Notably, ectopic expression of WWOX
together with Egr/TNFα did not result in any further increase inWWOX levels (S1 Fig). Together
these data demonstrate that WWOX contributes to Egr/TNFα-mediated cell death phenotype.
To determine whether the interaction between WWOX and Egr/TNFα was specific we also
tested the contribution of WWOX with other inducers of cell death. Given the significant anal-
ysis of WWOX function together with p53 in the literature, we also tested for any modification
of ectopic p53 phenotypes with altered levels of WWOX. However, we were unable to detect
any alteration to the much more severe eye phenotypes generated by ectopic expression of
either p53 or Hid (head involution defective), another of the cell death promoting proteins
identified in D.melanogaster (S2 Fig).
Egr/TNFα-mediated cell death phenotypes are mediated by increased
ROS
Reactive oxygen species (ROS) are known to be principle effector molecules of Egr/TNFα-
mediated cell death [45]. We were able to confirm this in larval wing discs expressing Egr/
TNFα in the posterior region by increased staining for CellRox compared to low levels
observed in the anterior control region for each disc (Fig 2A–2C). We also determined whether
the Egr/TNFα-mediated rough eye phenotypes can be modified by enzymes known to modify
ROS levels. Superoxide dismutase (SOD) activity is required for conversion of superoxide to
WWOX and the Elimination of Tumorigenic Cells
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Fig 1. AlteredWWOXmodifies ectopic Egr/TNFα-mediated eye phenotype. (A) Ectopic expression of
Egr/TNFα (GMR>egr+w>empty vector (EV)) results in a decrease in eye size and disruption to ommatidial
patterning. (B) The ectopic Egr/TNFα phenotype is completely suppressed by decreased levels of TNFR
(GMR>egr+w>wengen/TNFR-IR). (C) Decreased expression of WWOX by RNAi knockdown
(GMR>egr+w>WWOX-IR#1) results in suppression of the rough eye phenotype. (D)Quantification of
increased eye size with independent WWOX knockdown constructs (GMR>egr+w>WWOX-IR#1 and
GMR>egr+w>WWOX-IR#2). (E) Increased expression of WWOX by ectopic expression of theWWOX cDNA
(GMR>egr+w>WWOX-cDNA) resulted in an enhancement of the Eiger/TNFα phenotype. (F)Quantification of
decreased eye size with independent ectopic expression constructs for WWOX (GMR>egr+w>WWOX-ORF
and GMR>egr+w>WWOX-cDNA). Significance indicated by **** = p <0.0001, * = p<0.05 and ns = not
significant.
doi:10.1371/journal.pone.0136356.g001
WWOX and the Elimination of Tumorigenic Cells
PLOS ONE | DOI:10.1371/journal.pone.0136356 August 24, 2015 4 / 19
hydrogen peroxide as an intermediary in the detoxification process. There are different SOD
enzymes found within the cell; SOD1 (CuZn) is located in cytoplasm whilst SOD2 (Mn) is
found in the mitochondria. Ectopic expression of either SOD1 or SOD2 gave no phenotype on
their own (Fig 2D–2F) but were able to obviously suppress the Egr/TNFα eye (Fig 2G–2I). This
suppression of the Egr/TNFα small eye phenotype was consistently observed in all progeny
and supports a role for ROS in these Egr/TNFα-mediated phenotypes.
WWOX remains cytoplasmically localised in response to ectopic Egr/
TNFα expression
Nuclear localisation of WWOX has been reported to be necessary for the cell death promoting
functions of WWOX in mammalian cells [42]. Although endogenous levels of WWOX are too
Fig 2. Ectopic expression of Egr/TNFα gives increased ROS and is suppressed by increased SOD
activity. (A) Ectopic expression of GFP and Egr/TNFα with hh-GAL4 in the posterior portion of wing discs of
wandering third instar larvae, GFP shows the region of ectopic expression (outlined by dotted line). (B)
Punctate CellRox staining revealed increased ROS levels at posterior edge of disc. (C)Merged image with
GFP in green and CellRox in red. (D) Control eye phenotype (GMR>EV) showing regular ordered arrays of
ommatidial units on the surface of the adult eye (E-F) Ectopic expression of SOD1 or SOD2 alone has no
effect. (G). Ectopic expression of Egr/TNFα in the eye (GMR>egr+w>EV) results in a decrease in eye size and
disruption to ommatidial patterning. (H-I) The ectopic Egr/TNFα phenotype is obviously suppressed by
increased levels of SOD1 or SOD2.
doi:10.1371/journal.pone.0136356.g002
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low to be detected in D.melanogaster, we have previously shown cytoplasmic localization of
ectopically expressed WWOX during embryonic development [49]. Here, we also determined
the localisation of ectopically expressed WWOX in differentiated cells of the developing eye
disc. GMR-GAL4 was used to ectopically express WWOX in all cells posterior to the morpho-
genetic furrow. WWOX expression can be visualised in cytoplasmic regions surrounding the
DAPI stained clusters of nuclei from photoreceptor cells (S3 Fig). A similar pattern of cyto-
plasmic WWOX expression was observed in the presence of ectopic Egr/TNFα expression (S3
Fig). Thus we observed no alteration to ectopic WWOX localisation in response to Egr/TNFα
in vivo. Given the small size and complex organisation of cells in the developing eye disc, the
effect of ectopic Egr/TNFα expression on the localisation of WWOX was also determined in
cells in the posterior compartment of the wing disc using hh-GAL4. Co-expression of GFP
allowed for the positive identification of cells in the region of ectopic expression. Ectopic
WWOX alone resulted in cytoplasmic staining with WWOX detected in regions surrounding
the DAPI stained nuclei throughout the posterior half of the disc (Fig 3A–3D). In the presence
of ectopic Egr/TNFα expression, the wing discs are smaller and there is significant disruption
to the region of the disc marked by GFP expression (Fig 3E). Closer examination of cells
located in the posterior region of the disc showed that ectopic WWOX remains clearly cyto-
plasmic as staining was observed complementary to the DAPI stained nuclei (Fig 3F–3H).
Thus there was no evidence in vivo for nuclear localisation of detectable levels of ectopic
WWOX in response to Egr/TNFα expression in eye or wing imaginal discs.
Ectopic Egr/TNFα alone promotes apoptosis and disrupts cellular
patterning in wing discs
Ectopic expression of Egr/TNFα alone in the posterior region of wing discs resulted in a signifi-
cant decrease in tissue size and disruption to compartment boundaries as visualised by GFP
expression (Fig 4E). In particular there is posterior GFP expression extending into the central
wing pouch region of the disc (Fig 4E’). In order to determine the identity of these cells, Cubitis
interruptus (Ci) staining was used as a marker of cells specific to the anterior portion of the
wing disc. In control discs the region corresponding to Ci staining is complementary to the
GFP expression pattern in the posterior region under control of hh-GAL4 thus defining the
boundary of these distinct cell types (Fig 4B). However, in response to ectopic Egr/TNFα
expression in the posterior region, there is now a region of Ci positive anterior cells overlapping
with the GFP positive posterior cells in the central wing pouch region (Fig 4F and 4F’). Thus
ectopic expression of Egr/TNFα has resulted in disruption to normal patterning of the wing
disc cells such that there is no longer a clear distinction between cells from the Ci staining por-
tion of the disc (i.e. the wild-type cells from the anterior region) and GFP positive cells from
the posterior part of the disc (i.e. cells ectopically expressing Egr/TNFα).
Furthermore, the GFP expression observed in this region of overlap was punctate in appear-
ance suggestive of increased cell death (Fig 4E’). To assess the cell death we examined immu-
nostaining for cleaved Caspase 3 [50]. Whilst negligible levels of Caspase 3 staining were
observed in control discs (Fig 4C), increased levels were observed in the central wing pouch
region of discs ectopically expressing Egr/TNFα (Fig 4G and 4G’). In addition, Caspase 3 stain-
ing was found to extend beyond the GFP region of the wing pouch in two distinct regions (Fig
4G’, asterisks). Similar localisation of Caspase 3 staining to these two regions has previously
been reported following ectopic expression of Hid or Src64B, together with the apoptosis inhib-
itor P35 in the posterior region of developing wing discs [51–52]. The extremities of these
regions have previously been shown to contain cells undergoing a process of Apoptosis-
induced Apoptosis (AiA) with Egr/TNFα shown to be required for the death signal [52]. Closer
WWOX and the Elimination of Tumorigenic Cells
PLOS ONE | DOI:10.1371/journal.pone.0136356 August 24, 2015 6 / 19
examination of Cell Rox staining (Fig 2B) also revealed increased ROS corresponding to these
two distinct regions. These results confirm that over-expression of a low level of Egr/TNFα in
the posterior compartment is sufficient to induce ROS and cell death in anterior regions, con-
sistent with a key role of Egr /TNFα as an activating signal for AiA.
WWOXmodifies Caspase 3 staining in response to ectopic Egr/TNFα
Since WWOX has been shown to modify adult eye phenotypes resulting from ectopic over-
expression of Egr/TNFα, we determined whether WWOX was also able to regulate the
increased region of Caspase 3 staining and consequent disruption to the patterning induced by
ectopic expression of Egr/TNFα in wing discs. Decreased WWOX activity together with
ectopic expression of Egr/TNFα in the posterior portion of the disc resulted in a decrease in the
relative area of Caspase 3 staining (Fig 5C, 5D and 5G). Conversely, increased WWOX
Fig 3. Ectopic Egr/TNFα has no obvious effect on cytoplasmically localizedWWOX. (A) Ectopic
expression of GFP andWWOX in the posterior portion of wing discs of wandering third instar larvae
(hh>GFP>WWOX), GFP shows the region of ectopic expression. (B)WWOX staining reveals expression
localized to areas complementary to the DAPI stained nuclei shown in (C) with the merged image shown in
(D). (E-H) Ectopic expression of WWOX in the presence of ectopic Egr/TNFα (hh>GFP>WWOX>egr+w) also
results in cytoplasmic localisation of WWOX. Nuclei/DAPI staining shown in blue andWWOX staining in
magenta. Boxed regions shown in A and E correspond to regions that are enlarged in B-D and F-H
respectively.
doi:10.1371/journal.pone.0136356.g003
WWOX and the Elimination of Tumorigenic Cells
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expression increased the relative area of Caspase 3 staining (Fig 5E–5G). Thus we have shown
that WWOX activity is required for, and can contribute to, cell death in Egr/TNFα expressing
cells via regulation of Caspase 3 activity. The outcome of this interaction at the interface
between wild-type cells in the anterior and the posterior Egr/TNFα expressing cells is sugges-
tive of competitive interactions between these two cell types.
Requirement for WWOX tumor suppressor activity in vivo
Competition occurs between cell types that are genetically distinct such that one has a competi-
tive advantage over the other. In order to determine whether decreased WWOX impacts on
Fig 4. Qualitative effects of ectopic Egr/TNFα and increased apoptosis in the larval imaginal wing
disc. (A) Control disc showing ectopic expression in the posterior region of wing discs using hh-GAL4
visualized by co-expression of GFP. (B) Ci staining of control discs show staining of the anterior compartment
and is complementary to the region of GFP expression. (C) Caspase 3 staining revealed low levels of
apoptosis in control imaginal wing discs. (D)Merged image where GFP is green, Caspase 3 staining is
magenta and Ci is yellow. (E-E’) Ectopic expression of Eiger/TNFα resulted in a significant decrease in disc
size and disruption to the pattern of GFP expression with punctate staining in the central wing pouch region.
(F-F’) Staining of the anterior compartment with Ci reveals expression beyond the boundary and overlapping
with the region of GFP expression. (G-G’) Caspase 3 staining reveals high levels of staining in the central
wing pouch region and in two distinct regions extending towards to anterior portion of the disc (indicated with
the red asterisks). (H-H’)Merged image (GFP is green, Caspase 3 is magenta and Ci is yellow). In all images
the dotted line outlines the regions of GFP expression corresponding to the posterior region of the discs. Red
boxes indicate the regions that are enlarged in E’-H’.
doi:10.1371/journal.pone.0136356.g004
WWOX and the Elimination of Tumorigenic Cells
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the ability of tumorigenic cells to compete with non-tumorigenic / normal cells we utilized the
well characterised system of mitotic clones of the cell polarity regulator Scribbled (Scrib). Epi-
thelial tissues in D.melanogaster where all cells are mutant for Scrib will overgrow and give rise
to tumours [53]. However tumorigenic clones of Scribmutant cells that are surrounded by
wild-type cells will be eliminated [46, 54]. Clones of Scribmutant cells generated in this way
using theMosaic Analysis with a Repressible CellMarker (MARCM) system are positively
labelled with GFP expression [55]. Many cells of the randomly generated mutant clones are
eliminated however this process is not complete and some remain and can be visualized by
patches of GFP positive cells in developing eye discs (Fig 6A and 6A’). These cells also corre-
spond to regions of disruption to the normal pattern of differentiation as visualised by Elav
staining during larval development (Fig 6B, 6B’, 6C and 6C’). When WWOX levels were
Fig 5. WWOXmodifies Caspase3 staining in wing pouch in response to ectopic Egr/TNFα. (A) Ectopic
expression of GFP and Eiger/TNFαwith hh-GAL4 in the posterior portion of wing discs of wandering third
instar larvae, GFP showing the regions of ectopic expression. (B) Caspase 3 staining reveals high levels of
apoptosis in the central wing pouch region as well as in two distinct regions extending towards the anterior.
(C) DecreasedWWOX expression results in a decrease in area of GFP expression. (D) DecreasedWWOX
expression results in a decreased region of Caspase 3 staining. (E) IncreasedWWOX expression results in
an increase in area of GFP expression. (F) IncreasedWWOX expression results in a increased region of
Caspase 3 staining. (G)Quantification of the area of Caspase 3 staining as a proportion of the area of the
whole disc for individual wing discs of each genotype. Significance indicated by * = p<0.05, ** = p<0.005.
doi:10.1371/journal.pone.0136356.g005
WWOX and the Elimination of Tumorigenic Cells
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reduced within these tumorigenic clones, an increase in the proportion of disc area with GFP
positive cells was observed despite no change to overall disc size (Fig 6D, 6D’, 6G and 6H).
These GFP positive cells were also found to correspond to regions disrupted in their differenti-
ation as visualised with Elav (Fig 6E, 6E’, 6F and 6F’). Thus a decrease of WWOX within the
clones of tumorigenic cells results in a mild but significant increase in their ability to compete,
observed as a decrease in their effective elimination during this larval stage.
These tumorigenic Scrib clones persist throughout development and differentiation of eye
tissue and result in mild adult eye phenotypes characterised by patches of roughness and disrup-
tion to ommatidial patterning (Fig 6I). This phenotype is enhanced whenWWOX is decreased
by RNAi knockdown within cells of the Scribmutant clones where eyes consistently showed a
significant decrease in size, as well as an increase in the frequency of black necrotic lesions of
increased size on the surface of the adult eye (Fig 6J–6L). This enhanced phenotype also corre-
sponds to an observed decrease in overall viability with flies with decreased WWOX expression
in Scribmutant clones showing a survival rate of 31.9% of that expected compared to 74.1% for
flies with the Scribmutant clones alone (p = 0.0016). A decrease in adult viability (or increase
in pupal lethality) has previously been reported as an indication of reduced elimination of Scrib
mutant clones in other genetic backgrounds [45–46, 56]. Thus we have demonstrated a cell
autonomous contribution fromWWOX for the elimination of tumorigenic cells in a whole ani-
mal model system. Similar effects on adult eye development were obtained when Scribmutant
clones were generated in eye discs where the whole animal had reducedWWOX function (het-
erozygous for either of two independent alleles ofWWOX) or where WWOX function is
completely removed (trans-heterozygous for independentWWOX alleles) (S4 Fig). Together
these findings confirm that there is a decrease in the effectiveness of the process whereby tumor-
igenic Scribmutant clones are eliminated whenWWOX activity is reduced either exclusively
within cells comprising the mutant clones or whenWWOX activity is reduced or completely
removed from all cells of the animal. Although mild effects were observed during developmental
stages they resulted in more significant outcomes at the end of differentiation.
Discussion
TheWWOX gene spanning FRA16D has previously been shown to have a variety of in vitro
contributions to known cell death pathways in different mammalian cell lines, however it is
unclear how these translate into a role in vivo, particularly in relation to the ability of WWOX
to act as a tumor suppressor. We have therefore utilized a well-characterized D.melanogaster
model of cell-cell competition to investigate an in vivo role for WWOX in the process of elimi-
nation of cancerous cells.
Significantly we determined an in vivo contribution byWWOX to the process whereby
clones of epithelial cells carrying tumorigenic mutations are eliminated by the surrounding
wild-type cells. The outcomes of competitive cell interactions in this way are essential contribut-
ing factors to the development of tumors in vivo [57]. We report here that reduction, or absence,
of WWOX activity specifically in the tumorigenic cells decreased the effectiveness of this elimi-
nation process. Although this cell autonomous requirement forWWOX activity resulted in rela-
tively mild effects on GFP expressing mutant cells in the eye imaginal discs, much more striking
effects were evident at later stages. Generation of Scribmutant clones in this way is analogous to
the accumulation of mutations in cells that can gain a competitive advantage over the surround-
ing wild-type (non-mutant) cells and ultimately give rise to human cancers. Thus, our results
show that endogenous WWOX plays a significant in vivo role in the process whereby mutation-
bearing cells are eliminated. Together these results represent a plausible mechanism for low
WWOX levels contributing to poor prognosis in various cancers [21–23,58].
WWOX and the Elimination of Tumorigenic Cells
PLOS ONE | DOI:10.1371/journal.pone.0136356 August 24, 2015 10 / 19
Fig 6. WWOX is required for elimination of Scribbled (Scrib)mutant clones. (A-A’) Clones of cells mutant for Scrib generated in the eye using the
MARCM system are positively labelled with GFP. (B-B’) Elav staining reveals absence of differentiated photoreceptors within a portion of Scribmutant
clones. (C-C’)Merged image showing GFP in green and Elav in magenta. (D-D’)GFP expressing Scribmutant clones with decreasedWWOX expression
(Scrib1;WWOX-IR). (E-E’) Elav staining reveals absence of differentiated photoreceptors within a portion of the Scrib1;WWOX-IRmutant clones. (F-F’)
Merged image showing GFP in green and Elav in magenta. Red boxes indicate the regions that are enlarged in D’-F’. (G)Quantification of the proportion of
GFP expressing cells showed a significant increase whenWWOX expression was decreased in the Scribmutant clonal tissue compared to the Scribmutant
clones alone. (H)Quantification of total area of the eye disc containing Scrib clones with and without WWOX knockdown revealed no significant difference. (I)
Clones of cells mutant for Scrib generated in the eye using the MARCM system result in a mild adult rough eye phenotype. (J) DecreasedWWOX expression
in the Scribmutant clones gave a stronger phenotype with a decreased eye size, significant disruption to ommatidial patterning and the presence of necrotic
lesions. (K)Quantification of the overall size of the adult eyes showed a significant decrease whenWWOX levels were knocked down in Scribmutant clones.
(L)Quantification of percentage of adult fly eye showing necrotic spots of different sizes: Small (550–3000 pixels), Medium (3000–5500 pixels) or Large
(>5500 pixels). Genotypes used in these experiments: Scrib1 = (ey-FLP1, UAS-mCD8-GFP;;tub-GAL4 FRT82B tub-GAL80/ FRT82B, Scrib1), Scrib1;
WWOX-IR = (ey-FLP1, UAS-mCD8-GFP; UAS-WWOX-IR#2/+;tub-GAL4 FRT82B tub-GAL80/ FRT82B, Scrib1). Significance indicated by * = p<0.05 and **
= p<0.005, ns = not significant.
doi:10.1371/journal.pone.0136356.g006
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We have also utilised D.melanogastermodels to dissect the cell death pathways to which
WWOX contributes in vivo. In mouse L929 cells, an ectopic increase in WWOX was found to
enhance TNFα-mediated cell death [42]. Consistent with this observation, altered WWOX lev-
els modulate the phenotype obtained from ectopic expression of Egr/TNFα in the eye of D.
melanogaster. WWOX was also previously shown to be an essential component of p53-medi-
ated apoptosis in NIH3T3 cells [42], however no impact of altered WWOX levels was observed
on the D.melanogaster eye phenotype from ectopic expression of p53. Similarly, no WWOX-
mediated alteration of the D.melanogaster eye phenotype from ectopic expression of hid was
observed herein, although others have reported a mild effect with further reduced WWOX lev-
els on ectopic hid expression in the D.melanogaster eye [59]. Together these data are consistent
with WWOX having a conserved, biologically significant role to play in the cell death mediated
by Egr/TNFα.
In vitro nuclear localisation of pro-apoptotic WWOX was reported in L929 cells [42] as well
as in MC7 cells in response to DNA damage [60]. However, we found no in vivo evidence for
nuclear localization of ectopic WWOX in the presence of ectopic TNFα expression, indicating
that the tumor suppressive functions may not be at the level of detection or alternatively they
may be mediated through cytoplasmic WWOX functions. Conflicting reports appear in the lit-
erature for the location of WWOX protein to various cytoplasmically localised organelles
including Golgi and mitochondria [16, 49]. Thus the localisation of WWOXmay vary in differ-
ent cell types and in response to different cellular stressors.
We observed no phenotypic effect with ectopic expression of WWOX alone, thus the cell
death promoting effects of WWOX may require that WWOX be activated or modified in some
way (e.g. phosphorylation) and may only become effective in vivo once cells are under some
type of stress. Reactive oxygen species (ROS) are known to be principle effector molecules of
TNFα-mediated cell death [45]. We have previously shown ectopic expression of WWOX
gives high levels of ROS whilst reduced levels of WWOX show decreased ROS in developing D.
melanogaster larvae [30]. Therefore, a likely mechanism by which WWOX contributes to the
Egr/TNFα-mediated cell death pathway is via its regulation of ROS (Fig 7). At least to some
extent, this occurs through regulation of the subset of ROS that are also responsive to enzymes
of the superoxide dismutase (SOD) family and we have previously shown alterations in iso-
forms of SOD1 in WWOXmutant flies as well as genetic interactions between WWOX and
SOD1 [30]. However the role for WWOX in the regulation of ROS levels may occur in a con-
text dependent manner given the opposing effects reported for altered ROS in response to
modified WWOX expression [61–62]. In addition, alterations to ROS levels would occur as a
consequence of cancer cells shifting their metabolism from oxidative phosphorylation to a
more glycolytic Warburg-based metabolism and we have previously shown that WWOX is
both responsive to, and contributes to aerobic metabolism [30–31]. The protein products of
other Common Fragile Site-associated genes; Fragile histidine triad (FHIT) at FRA3B and Par-
kin at FRA6E have also previously been shown to act as regulators of ROS [63–65]. Thus these
genes may act together to maintain genome integrity under conditions of heightened oxidative
stress, potentially arising from alterations to cellular aerobic metabolism known to be associ-
ated with cancer.
Materials and Methods
Fly lines and crosses
w1118, UAS-Dmp53 [66], GMR-GAL4, GMR-hid [67], hh-GAL4 [68–69], UAS-SOD1 and
UAS-SOD2 [70] were provided by Bloomington Stock Centre. UAS-TNFR-IR (v9152),
UAS-WWOX-IR#1 (v22536), and UAS-WWOX-IR#2 (v108350) were obtained from Vienna
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Drosophila RNAi Center. Successful knockdown of WWOXmRNA in each of these lines has
previously been shown to be effective by quantitative real-time PCR (30, 61). Ectopic Eiger/
TNFα expression stock (UAS-egr+w) was kindly provided by Professor Miura [46].WWOX1,
WWOX2, UAS-WWOX ORF#1 and UAS-WWOX cDNA#1 have previously been described [49
and 61]. MARCMIII and FRT82B, Scrib1 stocks were kindly provided by Helena Richardson.
D.melanogaster stocks were maintained on fortified (F1) medium composed of 1% agar, 1%
glucose, 6% fresh yeast, 9.3% molasses, 8.4% coarse semolina, 0.9% acid mix and 1.7% tegosept.
All crosses were carried out at 25°C unless otherwise stated.
Analyses of Adult Eyes
Photographs of exterior adult female D.melanogaster eyes were taken using an Olympus SZX7
microscope fitted with a SZX-AS aperture diaphragm unit. Images were captured using an
Olympus ColourView IIIU Soft Imaging System camera and AnalysisRuler image acquisition
software. Images prepared using Adobe Photoshop CS version 8.0. The anterior of eye is posi-
tioned to the left of all images. For determination of adult eye sizes the outline of ten different
randomly selected eye photos were traced using ImageJ and total area (in pixels) for each
image was measured. Results for each experiment were graphed as scatterplot and statistical
analyses (T-test analyses and One Way ANOVA) performed in GraphPad Prism.
Clonal analyses
Mitotic clones were generated for analyses using the MARCM III system, by crossing ey-FLP1,
UAS-mCD8-GFP;;tub-GAL4 FRT82B tub-GAL80/TM6B flies to those carrying either aWWOX
mutant allele orWWOXRNAi transgene together with FRT82B, Scrib1. Timed lays were carried
out for all eye disc analyses. Third instar wandering larvae were dissected in PBS and fixed with
4% formaldehyde before mounting in glycerol to visualise GFP expression (GFP indicative of
Fig 7. Model for the conserved role of WWOX in TNFα-mediated apoptosis in vivo inD.melanogaster.
The function of WWOX in promoting cell death in response to Egr/TNFα signalling (throughWengen/TNFR)
is mediated by ROS and Caspase 3. This can be modulated though expression of SOD enzymes that act to
limit cellular levels of ROS and is also responsive to the metabolic status of cells.
doi:10.1371/journal.pone.0136356.g007
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clones and a minimum n = 20 eye discs were analysed per genotype). Significant disruption to
eye disc morphology was observed in 13/52 pairs of the Scrib1 clones and 31/50 pairs Scrib1;
WWOX-IR clones and these were not included in these analyses. The size of the whole eye disc
and area of GFP clones were quantified using Image J. The clonal area was calculated as a per-
centage of the total size of the eye imaginal disc and the averaged results were graphed as a scat-
terplot. T-test analyses were performed using GraphPad Prism. For determination of necrotic
spots, the area of the black regions on the surface of the adult eyes were measured using ImageJ
and divided into/scored as different categories based on size; small (550–3000 pixels), medium
(3000–5500 pixels) or large (>5500 pixels). The percentage of eyes in each category was calcu-
lated and graphed using Microsoft Excel. For the viability assays, the overall number of adult
progeny that eclosed from pupae were scored and the ratio of non TM6B:TM6B progeny were
recorded for each cross, as described previously (30). The survival rate is presented as a per-
centage of the expected ratio of progeny. Statistical analyses were performed using the chi-
square test with p = 0.05 as cut off value for significance using GraphPad Prism.
Western blot analyses
30 female adult flies (0–1 day old) per sample were collected and Western blot analyses were
performed as previously described (49). Primary antibodies used were anti-C-DmWWOX
antibody (1:1000) (49) and mouse monoclonal anti-β-tubulin antibody (1:2000, Sigma). Sec-
ondary antibodies used were Anti-Rabbit DyLight 649 antibody (1:2500, Vector Laboratories)
and anti-mouse-Cy3antibody (1:200, Jackson Laboratories).
Immunohistochemistry
Wing discs or eye imaginal discs were dissected from late third instar larvae in 1x phosphate buff-
ered saline (PBS) and fixed in 3.7% formaldehyde for 20 minutes. Discs were then washed three
times with PBST (1xPBS + 0.3% Triton-X-100) for 20 minutes and blocked with PBSTF (1xPBS
containing 5% fetal calf serum) for 90 minutes, followed by incubation of primary antibody over-
night at 4°C. Anti-C-DmWWOX antibody (1:100 (52), anti-cleaved Caspase 3 antibody (1:100,
Cell Signaling), anti-Elav 9F8A9 (1:10, Developmental Studies Hybridoma Bank) and anti-Ci 2A1
(1:100, Developmental Studies Hybridoma Bank) were used as primary antibodies. Discs were
washed with PBST three times for 20 minutes and blocked with PBSTF for 30 minutes, followed
by incubation of secondary antibody in the dark at room temperature for 2 hours. Secondary anti-
bodies used were Anti-Rabbit DyLight 649 antibody (1:100, Vector Laboratories) and Anti-Rat
rhodamine antibody (1:100). Discs were then washed three times with PBST for 20 minutes before
incubation of DAPI (1:1000) for five minutes at room temperature and mounting in 80% glycerol.
Relative areas of Caspase 3 staining were quantified in Image J and analysed in GraphPad Prism.
Cell ROS Assay
Reactive oxygen species (ROS) in third instar wing disc were detected using the fluorogenic
probe CellRox (Life Technologies) as described previously [70].
Supporting Information
S1 Fig. Altered WWOXmodifies ectopic Egr/TNFα-mediated eye phenotype. (A) Ectopic
expression of Egr/TNFα (GMR>egr+w>+) results in a decrease in eye size and disruption to
ommatidial patterning. (B) Decreased expression of WWOX by RNAi knockdown (GMR>
egr+w>WWOX-IR#2) resulted in suppression of the rough eye phenotype. (C) Decreased
expression of WWOX by heterozygous null allele (GMR>egr+w>WWOX1/+) resulted in
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suppression of the rough eye phenotype. (D) Decreased expression of WWOX by heterozygous
insertion mutation allele (GMR>egr+w>WWOX2/+) resulted in suppression of the rough eye
phenotype. (E) Increased expression of WWOX (GMR>egr+w>WWOX-ORF) resulted an
enhancement of the Egr/TNFα phenotype. (F)Quantification of increased eye size with indepen-
dent heterozygousWWOX alleles (GMR>egr+w>WWOX1/+ and GMR>egr+w>WWOX2/+).
(G) Increased expression of WWOX alone by ectopic expression of the ORF for WWOX
(GMR>WWOX-ORF) resulted in no effect on development of the adult eye. (H)Western blot
analysis and (I) quantification of the relative levels of WWOX protein expressed in each of the
ectopic expression lines compared to a β-Tubulin control. (J)Western blot analysis and (K)
quantification of WWOX protein expressed alone and together with Egr/TNFα compared to a
β-Tubulin control.
(TIF)
S2 Fig. Altered WWOX has no effect on ectopic p53 or Hid eye phenotypes. (A) Ectopic
expression of Dmp53 in the developing eye (GMR>DmP53>EV) at 18°C in the adult eye
results in a phenotype characterized by decrease in eye size and significant disruption to
ommatidial patterning accompanied by loss of pigment and the presence of small necrotic
lesions. (B) Decreased expression of WWOX by RNAi (GMR>DmP53>WWOX-IR#1) resulted
in no significant modification. (C) Increased expression of WWOX (GMR>DmP53>WWOX-
cDNA) also resulted in no significant modification. (D) Ectopic expression of head involution
defective in the adult eye (GMR>GMR-Hid>EV) results in a very strong rough eye phenotype
with reduction in eye size and almost complete loss of ommatidial structures. (E) Decreased
expression of WWOX by RNAi (GMR>GMR-Hid>WWOX-IR#1) resulted in no significant
modification. (F) Increased expression of WWOX (GMR>GMR-Hid>WWOX-cDNA) also
resulted in no significant modification.
(TIF)
S3 Fig. Ectopic Egr/TNFα has no effect on the cytoplasmic localization of WWOX in the
eye imaginal disc. (A-D) Ectopic expression of WWOX alone with GMR-gal4 results in
WWOX localisation to areas complementary to the DAPI stained nuclei of eye-imaginal discs
of wandering third instar larvae. (E-H) Ectopic expression of WWOX with GMR-gal4 in the
presence of ectopic Egr/TNFα expression also results in WWOX localisation to areas comple-
mentary to the DAPI stained nuclei of eye-imaginal discs of wandering third instar larvae.
(TIF)
S4 Fig. WWOX is required for elimination of Scribbled (Scrib)mutant clones in adult eyes.
(A) Clones of cells mutant for Scrib generated in the eye using the MARCM system result in a
mild adult rough eye phenotype. (B) Decreased WWOX expression throughout the whole ani-
mal (Scrib1;WWOX1/+) resulted in a stronger phenotype with a decreased eye size, significant
disruption to ommatidial patterning and the presence of some necrotic lesions. (C) Complete
absence of WWOX throughout the whole animal (Scrib1;WWOX1/ WWOX2) resulted in a
phenotype with a decreased eye size, significant disruption to ommatidial patterning and the
presence of large necrotic lesions. Genotypes used: Scrib1 (ey-FLP1, UAS-mCD8-GFP; +/+;tub-
GAL4 FRT82B tub-GAL80/ FRT82B scrib1), Scrib1;WWOX-/+(ey-FLP1, UAS-mCD8-GFP;
WWOX1/+;tub-GAL4 FRT82B tub-GAL80/ FRT82B scrib1), Scrib1;WWOX-/- = (ey-FLP1,
UAS-mCD8-GFP; WWOX1/ WWOX2;tub-GAL4 FRT82B tub-GAL80/ FRT82B scrib1). Adults
carryingWWOXmutations were generated by crossing ey-FLP1, UAS-mCD8-GFP;;tub-GAL4
FRT82B tub-GAL80/TM6B flies carrying either aWWOXmutant allele or wild-type second
chromosome together with FRT82B, Scrib1 carrying aWWOXmutant allele.
(TIF)
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